Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, December 11, 2020
Passage Bio and Catalent announced manufacturing operations have commenced to support AAV production for Passage Bio’s lead gene therapy product candidates for the treatment of rare monogenic CNS disorders.
read more
Friday, December 11, 2020
Viatris has expanded on the restructuring program announced by Mylan earlier this year.
read more
Friday, December 11, 2020
Catalent announced the appointment of Nakaya “Nick” Matsumaru as General Manager of its new clinical packaging facility in Minakuchi, located in the Shiga prefecture of Japan.
read more
Friday, December 11, 2020
PostEra has announced a strategic partnership with Pfizer with the goal of accelerating small molecule drug discovery by developing a platform technology based on generative chemistry.
read more
Thursday, December 10, 2020
LIPAC Oncology and Huons announced the achievement of a development milestone in their partnering agreement by finalizing its Clinical Study Report for a Phase 2A marker lesion clinical trial in patients with low-grade highly recurrent NMIBC treated ...
read more
Thursday, December 10, 2020
Syneos Health has completed the previously announced acquisition of Synteract, a CRO focused on the biopharma segment.
read more
Thursday, December 10, 2020
Lonza has announced an investment to expand its particle engineering and drug product capabilities at its Oregon site.
read more
Thursday, December 10, 2020
Fusion Antibodies and Queen’s University Belfast have been awarded a £453,000 grant from Invest Northern Ireland to further expand their COVID-19 targeted research and development efforts.
read more
Thursday, December 10, 2020
Recipharm has announced an investment and capacity expansion at its facility in Israel.
read more
Wednesday, December 09, 2020
GBG and its CRO arm GD3 has expanded its relationship with Yale University to continue to offer GD3's integrated portfolio of preclinical services to the awardees of the Blavatnik Fund for Innovation.
read more
Wednesday, December 09, 2020
Vectura has signed a global license and development agreement with Kinaset for VR588, a preclinical novel inhaled pan-JAK inhibitor for prevention and treatment of severe asthma.
read more
Wednesday, December 09, 2020
SGS has announced the recruitment of the first participants in the US who will be taking part in a multinational clinical trial of a potential drug candidate for those suffering with COVID-19 related respiratory failure.
read more
Wednesday, December 09, 2020
Stelis BioSource has started the next phase of its continued investment program after having already invested well over $100m into its facilities in Bangalore, India.
read more
Wednesday, December 09, 2020
PathoQuest has received support from the Île-de-France region as part of the PM’up Relance Industrie program to accelerate the industrialization of the company’s high value-added service for quality control testing of biologics.
read more
Wednesday, December 09, 2020
Logistics4Pharma recently completed a successful inspection to validate GDP for the storage and transportation of APIs and finished drug products.
read more